Promising clinical data surrounding Retatrutide , specifically the 120 milligram formulation ZPHC ZPHC, reveal a considerable benefit on body mass decrease and linked chronic illnesses . Experts posit that this dual compound, affecting both GLP-1 and GIP pathways , may represent a major advance